CD274 and breast carcinoma: Further, Nanodrug (MS NPs), self-assembled from metformin and anticancer agent 7-ethyl-10-hydroxycamptothecin (SN38), was developed to suppress PD-L1 expression, enhancing the anti-tumor effect of combined immunotherapy and chemotherapy in breast cancer [244].